# Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

> **NCT00985855** · PHASE2 · COMPLETED · sponsor: **Institut de Cancérologie de la Loire** · enrollment: 91 (actual)

## Conditions studied

- Non-Small-Cell Lung Carcinoma

## Interventions

- **DRUG:** cisplatin, vinorlebine, cetuximab
- **DRUG:** cisplatine, etoposide, cetuximab

## Key facts

- **NCT ID:** NCT00985855
- **Lead sponsor:** Institut de Cancérologie de la Loire
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2017-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00985855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00985855, "Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00985855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*